These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9014288)

  • 21. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site.
    Lamikanra A; Pan ZK; Isaacs SN; Wu TC; Paterson Y
    J Virol; 2001 Oct; 75(20):9654-64. PubMed ID: 11559797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses.
    Park DS; Selvey LA; Kelsall SR; Frazer IH
    J Virol Methods; 1993 Dec; 45(3):303-18. PubMed ID: 8106603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Construction of recombinant vaccinia virus expressing HPV18E7E6 fusion proteins and detection of its immunogenicity in mice].
    Zhao L; Ren J; Feng J; Gao J; Zhang H; Tian HW; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):189-91. PubMed ID: 19031699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.
    Adams M; Borysiewicz L; Fiander A; Man S; Jasani B; Navabi H; Lipetz C; Evans AS; Mason M
    Vaccine; 2001 Mar; 19(17-19):2549-56. PubMed ID: 11257391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical studies of human papilloma vaccines in cervical cancer.
    Adams M; Borysiewicz L; Fiander A; Man S; Jasani B; Navabi H; Evans AS; Mason M
    Adv Exp Med Biol; 2001; 495():419-27. PubMed ID: 11774604
    [No Abstract]   [Full Text] [Related]  

  • 27. A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity.
    Rosales C; Graham VV; Rosas GA; Merchant H; Rosales R
    Cancer Immunol Immunother; 2000 Sep; 49(7):347-60. PubMed ID: 10999461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient expression of modified human papillomavirus 16 e6/e7 fusion protein and the antitumor efficacy in a mouse model.
    Zhou X; Qian X; Zhao Q; Lu Y; Xiong M
    Biol Pharm Bull; 2004 Mar; 27(3):303-7. PubMed ID: 14993792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.
    He Z; Wlazlo AP; Kowalczyk DW; Cheng J; Xiang ZQ; Giles-Davis W; Ertl HC
    Virology; 2000 Apr; 270(1):146-61. PubMed ID: 10772987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin.
    Hsieh CJ; Kim TW; Hung CF; Juang J; Moniz M; Boyd DA; He L; Chen PJ; Chen CH; Wu TC
    Vaccine; 2004 Sep; 22(29-30):3993-4001. PubMed ID: 15364449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.
    Nimako M; Fiander AN; Wilkinson GW; Borysiewicz LK; Man S
    Cancer Res; 1997 Nov; 57(21):4855-61. PubMed ID: 9354449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
    Tan TM; Gloss B; Bernard HU; Ting RC
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
    Valmori D; Lévy F; Miconnet I; Zajac P; Spagnoli GC; Rimoldi D; Liénard D; Cerundolo V; Cerottini JC; Romero P
    J Immunol; 2000 Jan; 164(2):1125-31. PubMed ID: 10623865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL; Qiu XH; Shen C; Liu JN; Zhang J
    Oncol Rep; 2010 Nov; 24(5):1323-9. PubMed ID: 20878127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction and identification of the replication-deficient recombinant vaccinia virus co-expressing HPV type 16 L1 and L2 proteins].
    Han L; Ren J; Liang Y; Tian H; Zhi H; Luo W; Lu Z; Wei L; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):256-60. PubMed ID: 12665934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillomavirus oncoproteins as vaccine candidates.
    Galloway DA
    Lancet; 1996 Jun; 347(9014):1498-9. PubMed ID: 8684094
    [No Abstract]   [Full Text] [Related]  

  • 37. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
    Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.
    Rice AE; Latchman YE; Balint JP; Lee JH; Gabitzsch ES; Jones FR
    Cancer Gene Ther; 2015 Sep; 22(9):454-62. PubMed ID: 26337747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response elicited by immunization with a recombinant vaccinia vector carrying the HPV16 E7 gene.
    Gabriel P; Babiarova K; Zurkova K; Krystofova J; Hainz P; Kutinova L; Nemeckova S
    Viral Immunol; 2012 Oct; 25(5):411-22. PubMed ID: 23035852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modification of HPV type 16 E6 and E7 genes, and analysis of stability and immunogenicity of the modified proteins].
    Zhi H; Han L; Ren J; Tian H; Luo W; Liang Y; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):124-7. PubMed ID: 12196821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.